Core Laboratories (CLB) Expected to Announce Earnings on Wednesday

Core Laboratories (NYSE:CLB - Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Wednesday, April 23rd. Analysts expect the company to announce earnings of $0.15 per share and revenue of $125.09 million for the quarter. Core Laboratories has set its Q1 2025 guidance at 0.120-0.160 EPS.Investors interested in listening to the company's conference call can do so using this link.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Stock Performance

Core Laboratories stock traded up $0.26 during mid-day trading on Friday, reaching $12.58. The company's stock had a trading volume of 835,655 shares, compared to its average volume of 388,010. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. Core Laboratories has a twelve month low of $10.14 and a twelve month high of $25.13. The business has a 50 day moving average price of $14.63 and a 200-day moving average price of $17.49. The firm has a market cap of $587.28 million, a price-to-earnings ratio of 19.05, a PEG ratio of 0.99 and a beta of 1.99.

Core Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Monday, February 10th were given a $0.01 dividend. The ex-dividend date of this dividend was Monday, February 10th. This represents a $0.04 annualized dividend and a yield of 0.32%. Core Laboratories's dividend payout ratio is presently 6.06%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on CLB shares. Citigroup raised Core Laboratories from a "sell" rating to a "neutral" rating and upped their target price for the company from $15.00 to $16.00 in a report on Wednesday, March 12th. Stifel Nicolaus decreased their price objective on shares of Core Laboratories from $19.00 to $15.00 and set a "hold" rating for the company in a research note on Tuesday. One investment analyst has rated the stock with a sell rating and four have issued a hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $15.75.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.